 |
| |||
| acute upper respiratory tract inflammation (Patients who were complicated by acute upper respiratory tract inflammation during the 7-day observation period prior to enrollment which may affect the nasal symptoms aldrignedigen) | |||
|
| |||
| acute upper respiratory tract inflammation (Patients who were complicated by acute upper respiratory tract inflammation during the 7-day observation period prior to enrollment which may affect the nasal symptoms aldrignedigen) | |||